Neil E. Bhola
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
Papers in
-
- Head and Neck Cancer Studies 15
- Oncology 14
- HER2/EGFR in Cancer Research 7
- Cancer Cells and Metastasis 4
- Co-authors
- Carlos L. Arteaga (9 shared papers)Jennifer Rubin Grandis (16 shared papers)Justin Micah Balko (4 shared papers)Melinda E. Sanders (4 shared papers)María Gabriela Kuba (2 shared papers)Teresa C. Dugger (3 shared papers)Violeta M. Sanchez (2 shared papers)Jamie C. Stanford (1 shared paper)
- Journals
- Cancer Research (9 papers)Clinical Cancer Research (5 papers)Molecular Cancer Therapeutics (2 papers)Journal of Clinical Investigation (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Neil E. Bhola
34 papers receiving 2.5k citations
Neil E. Bhola's Hit Papers
Peers
Comparison fields: 5 of 79
- Otorhinolaryngology 248
- Oncology 801
- Cancer Research 480
- Molecular Biology 818
- Pulmonary and Respiratory Medicine 298
Countries citing papers authored by Neil E. Bhola
This map shows the geographic impact of Neil E. Bhola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil E. Bhola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil E. Bhola more than expected).
Fields of papers citing papers by Neil E. Bhola
This network shows the impact of papers produced by Neil E. Bhola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil E. Bhola. The network helps show where Neil E. Bhola may publish in the future.
Co-authors
The 25 scholars most cited alongside Neil E. Bhola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer Hit paper breakdown → | 2013 | 515 |
| 2 | 2012 | 223 | |
| 3 | 2017 | 202 | |
| 4 | 2017 | 192 | |
| 5 | 2013 | 131 | |
| 6 | 2006 | 124 | |
| 7 | 2012 | 108 | |
| 8 | 2017 | 108 | |
| 9 | 2016 | 94 | |
| 10 | 2010 | 92 | |
| 11 | 2015 | 86 | |
| 12 | 2018 | 79 | |
| 13 | 2007 | 73 | |
| 14 | 2014 | 54 | |
| 15 | 2019 | 50 | |
| 16 | 2016 | 48 | |
| 17 | 2021 | 46 | |
| 18 | 2015 | 44 | |
| 19 | 2019 | 42 | |
| 20 | 2015 | 34 |
About Neil E. Bhola
Neil E. Bhola is a scholar working on Otorhinolaryngology, Oncology, Molecular Biology, Cancer Research and Rehabilitation, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (15 papers), HER2/EGFR in Cancer Research (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer Cells and Metastasis (4 papers), TGF-β signaling in diseases (3 papers), DNA Repair Mechanisms (2 papers), Bioinformatics and Genomic Networks (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Otorhinolaryngology (248 citations), Oncology (801 citations), Cancer Research (480 citations), Molecular Biology (818 citations) and Pulmonary and Respiratory Medicine (298 citations). Neil E. Bhola has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Carlos L. Arteaga, Jennifer Rubin Grandis, Justin Micah Balko, Melinda E. Sanders, María Gabriela Kuba, Teresa C. Dugger, Violeta M. Sanchez, Jamie C. Stanford, Rebecca S. Cook and Stefan Hartmann. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Investigation and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.